Viral and cellular MARCH ubiquitin ligases and cancer

Seminars in Cancer Biology

Volumn 18, Issue 6, 2008, Pages 441-450

  Wang, Xiaoli ^a   Herr, Roger A ^a   Hansen, Ted ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Herpesvirus 68; Degradation pathways; Immune evasion; Intracellular trafficking; Kaposi's sarcoma associated herpes virus; Ubiquitination

Indexed keywords

CELL ENZYME; MARCH PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN;

CELL CYCLE REGULATION; ENDOCYTOSIS; ENZYME DEGRADATION; HUMAN; LYSOSOME; NEOPLASM; NONHUMAN; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; SEQUENCE ALIGNMENT; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; UBIQUITINS; VIRAL PROTEINS;

EID: 56949087771     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2008.09.002     Document Type: Review

References (113)

1. Pickart C.M., and Fushman D. Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 8 (2004) 610-616
2. Hochstrasser M. Lingering mysteries of ubiquitin-chain assembly. Cell 124 (2006) 27-34
3. Fang S., and Weissman A.M. A field guide to ubiquitylation. Cell Mol Life Sci 61 (2004) 1546-1561
4. Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem 70 (2001) 503-533
5. Jin J., Li X., Gygi S.P., and Harper J.W. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 447 (2007) 1135-1138
6. Freemont P.S. RING for destruction?. Curr Biol 10 (2000) R84-R87
7. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., and Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96 (1999) 11364-11369
8. Staub O., and Rotin D. Role of ubiquitylation in cellular membrane transport. Physiol Rev 86 (2006) 669-707
9. Thrower J.S., Hoffman L., Rechsteiner M., and Pickart C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J 19 (2000) 94-102
10. Newton K., and Vucic D. Ubiquitin ligases in cancer: ushers for degradation. Cancer Invest 25 (2007) 502-513
11. Mani A., and Gelmann E.P. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23 (2005) 4776-4789
12. Fang S., Lorick K.L., Jensen J.P., and Weissman A.M. RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin Cancer Biol 13 (2003) 5-14
13. Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8 (2006) 645-654
14. Burger A.M., and Seth A.K. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer 40 (2004) 2217-2229
15. Kikkert M., Doolman R., Dai M., Avner R., Hassink G., van Voorden S., et al. Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem 279 (2004) 3525-3534
16. Bays N.W., Gardner R.G., Seelig L.P., Joazeiro C.A., and Hampton R.Y. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat Cell Biol 3 (2001) 24-29
17. Deak P.M., and Wolf D.H. Membrane topology and function of Der3/Hrd1p as a ubiquitin-protein ligase (E3) involved in endoplasmic reticulum degradation. J Biol Chem 276 (2001) 10663-10669
18. Yamasaki S., Yagishita N., Sasaki T., Nakazawa M., Kato Y., Yamadera T., et al. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J 26 (2007) 113-122
19. Kostova Z., Tsai Y.C., and Weissman A.M. Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol 18 (2007) 770-779
20. Watanabe H., Nabi I.R., and Raz A. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res 51 (1991) 2699-2705
21. Nabi I.R., Watanabe H., Silletti S., and Raz A. Tumor cell autocrine motility factor receptor. EXS 59 (1991) 163-177
22. Tsai Y.C., Mendoza A., Mariano J.M., Zhou M., Kostova Z., Chen B., et al. The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med 13 (2007) 1504-1509
23. Lerner M., Corcoran M., Cepeda D., Nielsen M.L., Zubarev R., Ponten F., et al. The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell 18 (2007) 1670-1682
24. Cohen A.J., Li F.P., Berg S., Marchetto D.J., Tsai S., Jacobs S.C., et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301 (1979) 592-595
25. Gemmill R.M., West J.D., Boldog F., Tanaka N., Robinson L.J., Smith D.I., et al. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci USA 95 (1998) 9572-9577
26. Li F.P., Decker H.J., Zbar B., Stanton Jr. V.P., Kovacs G., Seizinger B.R., et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Genetics of familial renal carcinoma. Ann Intern Med 118 (1993) 106-111
27. Brauweiler A., Lorick K.L., Lee J.P., Tsai Y.C., Chan D., Weissman A.M., et al. RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene 26 (2007) 2263-2271
28. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., and Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84 (1996) 769-779
29. Bouvier M. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol 39 (2003) 697-706
30. Lilley B.N., and Ploegh H.L. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 207 (2005) 126-144
31. Virgin H.W., Latreille P., Wamsley P., Hallsworth K., Weck K.E., DalCanto A.J., et al. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71 (1997) 5894-5904
32. Lybarger L., Wang X.L., Harris M., and Hansen T.H. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways. Curr Opin Immunol 17 (2005) 71-78
33. Stevenson P.G., Efstathiou S., Doherty P.C., and Lehner P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci USA 97 (2000) 8455-8460
34. Boname J.M., and Stevenson P.G. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15 (2001) 627-636
35. Kikkert M., Hassink G., Barel M., Hirsch C., van der Wal F.J., and Wiertz E. Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem J 358 (2001) 369-377
36. Shamu C.E., Flierman D., Ploegh H.L., Rapoport T.A., and Chau V. Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. Mol Biol Cell 12 (2001) 2546-2555
37. Carvalho P., Goder V., and Rapoport T.A. Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126 (2006) 361-373
38. Fruh K., Bartee E., Gouveia K., and Mansouri M. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res 88 (2002) 55-69
39. Coscoy L., and Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97 (2000) 8051-8056
40. Ishido S., Wang C., Lee B.S., Cohen G.B., and Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74 (2000) 5300-5309
41. Dodd R.B., Allen M.D., Brown S.E., Sanderson C.M., Duncan L.M., Lehner P.J., et al. Solution structure of the Kaposi's sarcoma-associated herpesvirus K3 N-terminal domain reveals a Novel E2-binding C4HC3-type RING domain. J Biol Chem 279 (2004) 53840-53847
42. Lehner P.J., Hoer S., Dodd R., and Duncan L.M. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207 (2005) 112-125
43. Pickart C.M. Ubiquitin enters the new millennium. Mol Cell 8 (2001) 499-504
44. Yu Y.Y.L., Harris M.R., Lybarger L., Kimpler L.A., Myers N.B., Virgin H.W., et al. Physical association of the K3 protein of gamma-2 herpesvirus 68 with major histocompatibility complex class 1 molecules with impaired peptide and beta(2)-microglobulin assembly. J Virol 76 (2002) 2796-2803
45. Duncan L.M., Piper S., Dodd R.B., Saville M.K., Sanderson C.M., Luzio J.P., et al. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J 25 (2006) 1635-1645
46. Hewitt E.W., Duncan L., Mufti D., Baker J., Stevenson P.G., and Lehner P.J. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J 21 (2002) 2418-2429
47. Lorenzo M.E., Jung J.U., and Ploegh H.L. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol 76 (2002) 5522-5531
48. Means R.E., Lang S.M., and Jung J.U. The Kaposi's sarcoma-associated herpesvirus K5 E3 ubiquitin ligase modulates targets by multiple molecular mechanisms. J Virol 81 (2007) 6573-6583
49. Means R.E., Ishido S., Alvarez X., and Jung J.U. Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein. EMBO J 21 (2002) 1638-1649
50. Boname J.M., de Lima B.D., Lehner P.J., and Stevenson P.G. Viral degradation of the MHC class I peptide loading complex. Immunity 20 (2004) 305-317
51. Sanchez D.J., Gumperz J.E., and Ganem D. Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115 (2005) 1369-1378
52. Ishido S., Choi J.K., Lee B.S., Wang C., DeMaria M., Johnson R.P., et al. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13 (2000) 365-374
53. Thomas M., Boname J.M., Field S., Nejentsev S., Salio M., Cerundolo V., et al. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci USA 105 (2008) 1656-1661
54. Li Q., Means R., Lang S., and Jung J.U. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81 (2007) 2117-2127
55. Mansouri M., Douglas J., Rose P.P., Gouveia K., Thomas G., Means R.E., et al. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108 (2006) 1932-1940
56. Lybarger L., Wang X.L., Harris M.R., Virgin H.W., and Hansen T.H. Virus subversion of the MHC class I peptide-loading complex. Immunity 18 (2003) 121-130
57. Wang X.L., Lybarger L., Connors R., Harris M.R., and Hansen T.H. Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J Virol 78 (2004) 8673-8686
58. Wang X.L., Connors R., Harris M.R., Hansen T.H., and Lybarger L. Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3. J Virol 79 (2005) 4099-4108
59. Wang X.L., Herr R.A., Chua W.J., Lybarger L., Wiertz E.J.H.J., and Hansen T.H. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J Cell Biol 177 (2007) 613-624
60. Cadwell K., and Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309 (2005) 127-130
61. Hassink G.C., Barel M.T., Van Voorden S.B., Kikkert M., and Wiertz E.J. Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11. J Biol Chem 281 (2006) 30063-30071
62. Binette J., Dube M., Mercier J., Halawani D., Latterich M., and Cohen E.A. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4 (2007) 75
63. Shamu C.E., Story C.M., Rapoport T.A., and Ploegh H.L. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol 147 (1999) 45-58
64. Yu H., and Kopito R.R. The role of multiubiquitination in dislocation and degradation of the alpha subunit of the T cell antigen receptor. J Biol Chem 274 (1999) 36852-36858
65. Tait S.W., de Vries E., Maas C., Keller A.M., D'Santos C.S., and Borst J. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J Cell Biol 179 (2007) 1453-1466
66. Lilley B.N., and Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429 (2004) 834-840
67. Ye Y., Shibata Y., Yun C., Ron D., and Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429 (2004) 841-847
68. Fiebiger E., Story C., Ploegh H.L., and Tortorella D. Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein. EMBO J 21 (2002) 1041-1053
69. Tirosh B., Furman M.H., Tortorella D., and Ploegh H.L. Protein unfolding is not a prerequisite for endoplasmic reticulum-to-cytosol dislocation. J Biol Chem 278 (2003) 6664-6672
70. Wang X.L., Ye Y.H., Lencer W., and Hansen T.H. The viral E3 ubiquitin ligase mK3 uses the derlin/p97 endoplasmic reticulum-associated degradation pathway to mediate down-regulation of major histocompatibility complex class I proteins. J Biol Chem 281 (2006) 8636-8644
71. Ye Y. Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J Struct Biol 156 (2006) 29-40
72. Goto E., Ishido S., Sato Y., Ohgimoto S., Ohgimoto K., Nagano-Fujii M., et al. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J Biol Chem 278 (2003) 14657-14668
73. Holzerlandt R., Orengo C., Kellam P., and Alba M.M. Identification of new herpesvirus gene homologs in the human genome. Genome Res 12 (2002) 1739-1748
74. Jenner R.G., and Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 1602 (2002) 1-22
75. Morokuma Y., Nakamura N., Kato A., Notoya M., Yamamoto Y., Sakai Y., et al. MARCH-XI, a novel transmembrane ubiquitin ligase implicated in ubiquitin-dependent protein sorting in developing spermatids. J Biol Chem 282 (2007) 24806-24815
76. Ohmura-Hoshino M., Goto E., Matsuki Y., Aoki M., Mito M., Uematsu M., et al. A novel family of membrane-bound E3 ubiquitin ligases. J Biochem 140 (2006) 147-154
77. Bartee E., Mansouri M., Nerenberg B.T.H., Gouveia K., and Fruh K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78 (2004) 1109-1120
78. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39 (1985) 783-791
79. Notredame C., Higgins D.G., and Heringa J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302 (2000) 205-217
80. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4 (1987) 406-425
81. de Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N., Pierre P., et al. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci USA 105 (2008) 3491-3496
82. Matsuki Y., Ohmura-Hoshino M., Goto E., Aoki M., Mito-Yoshida M., Uematsu M., et al. Novel regulation of MHC class II function in B cells. EMBO J 26 (2007) 846-854
83. Thibodeau J., Bourgeois-Daigneault M.C., Huppe G., Tremblay J., Aumont A., Houde M., et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 38 (2008) 1225-1230
84. Ohmura-Hoshino M., Matsuki Y., Aoki M., Goto E., Mito M., Uematsu M., et al. Inhibition of MHC class II expression and immune responses by c-MIR. J Immunol 177 (2006) 341-354
85. Cadwell K., and Coscoy L. The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets. J Virol 82 (2008) 4184-4189
86. Hoer S., Smith L., and Lehner P.J. MARCH-IX mediates ubiquitination and downregulation of ICAM-1. FEBS Lett 581 (2007) 45-51
87. Christensen D.E., Brzovic P.S., and Klevit R.E. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol 14 (2007) 941-948
88. Nakamura N., Kimura Y., Tokuda M., Honda S., and Hirose S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7 (2006) 1019-1022
89. Karbowski M., Neutzner A., and Youle R.J. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 178 (2007) 71-84
90. Yonashiro R., Ishido S., Kyo S., Fukuda T., Goto E., Matsuki Y., et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J 25 (2006) 3618-3626
91. Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., et al. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275 (1997) 73-77
92. Hassink G., Kikkert M., van Voorden S., Lee S.J., Spaapen R., van Laar T., et al. TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochemical Journal 388 (2005) 647-655
93. Kreft S.G., Wang L., and Hochstrasser M. Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI). J Biol Chem 281 (2006) 4646-4653
94. Fukuda H., Nakamura N., and Hirose S. MARCH-III is a novel component of endosomes with properties similar to those of MARCH-II. J Biochem 139 (2006) 137-145
95. Nakamura N., Fukuda H., Kato A., and Hirose S. MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking. Mol Biol Cell 16 (2005) 1696-1710
96. Bock J.B., Klumperman J., Davanger S., and Scheller R.H. Syntaxin 6 functions in trans-Golgi network vesicle trafficking. Mol Biol Cell 8 (1997) 1261-1271
97. Bock J.B., Lin R.C., and Scheller R.H. A new syntaxin family member implicated in targeting of intracellular transport vesicles. J Biol Chem 271 (1996) 17961-17965
98. Lu H., and Bilder D. Endocytic control of epithelial polarity and proliferation in Drosophila. Nat Cell Biol 7 (2005) 1232-1239
99. Cao Z., Huett A., Kuballa P., Giallourakis C., and Xavier R.J. DLG1 is an anchor for the E3 ligase MARCH2 at sites of cell-cell contact. Cell Signal 20 (2008) 73-82
100. Baker R.K., Haendel M.A., Swanson B.J., Shambaugh J.C., Micales B.K., and Lyons G.E. In vitro preselection of gene-trapped embryonic stem cell clones for characterizing novel developmentally regulated genes in the mouse. Dev Biol 185 (1997) 201-214
101. Metcalfe S.M., Muthukumarana P.A., Thompson H.L., Haendel M.A., and Lyons G.E. Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance. FEBS Lett 579 (2005) 609-614
102. Muthukumarana P.A., Lyons G.E., Miura Y., Thompson L.H., Watson T., Green C.J., et al. Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance. Int Immunopharmacol 6 (2006) 1993-2001
103. Nathan JA, Sengupta S, Wood SA, Admon A, Markson G, Sanderson C, et al. The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating Enzymes USP7 and USP9X. Traffic; 2008.
104. Schwartz R.M., and Dayhoff M.O. Matrices for detecting distant relationships. In: Dayhoff M.O. (Ed). Atlas of protein sequence and structure, vol. 5, suppl. 3 (1978), National Biomedical Research Foundation, Washington, D.C pp. 353-8
105. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24 (2007) 1596-1599
106. Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N., et al. Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res 5 (1998) 31-39
107. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., and Melton D.A. Stemness: transcriptional profiling of embryonic and adult stem cells. Science 298 (2002) 597-600
108. Metcalfe S.M. Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance. Philos Trans R Soc Lond B Biol Sci 360 (2005) 1687-1694
109. Muthukumarana P., Chae W.J., Maher S., Rosengard B.R., Bothwell A.L., and Metcalfe S.M. Regulatory transplantation tolerance and "stemness": evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcription. Transplantation 84 (2007) S6-11
110. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99 (2002) 4465-4470
111. Boll W., Ohno H., Songyang Z., Rapoport I., Cantley L.C., Bonifacino J.S., et al. Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes. EMBO J 15 (1996) 5789-5795
112. Fuhrer C., Geffen I., Huggel K., and Spiess M. The two subunits of the asialoglycoprotein receptor contain different sorting information. J Biol Chem 269 (1994) 3277-3282
113. Owen D.J., and Evans P.R. A structural explanation for the recognition of tyrosine-based endocytotic signals. Science 282 (1998) 1327-1332